CROCuS, a Phase II Study Evaluating the Antiviral Activity, Clinical Outcomes, and Safety of Rilematovir in Children Aged ≥ 28 Days and ≤ 3 Years with Acute Respiratory Tract Infection Due to Respiratory Syncytial Virus.
Fernando Claudio FerreroChien-Yu LinJohannes LieseKleber Giovanni LuzTatyana StoevaAgnes NemethManuel GijónChristina CalvoSilvina Natalini MartínezTeck-Hock TohSofie DeleuBohang ChenSarah RuschBeatriz López SánchezIllse LeipoldtLeen VijgenDymphy HuntjensTristan BaguetKristi BertzosMohamed GamilMarita Stevensnull nullPublished in: Paediatric drugs (2024)
EudraCT Number: 2016-003642-93; ClinicalTrials.gov Identifier: NCT03656510. First posted date: 4 September, 2018.